Literature DB >> 10088620

Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer.

E L Franco1, T E Rohan, L L Villa.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10088620     DOI: 10.1093/jnci/91.6.506

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  38 in total

1.  HPV typing and its relation with apoptosis in cervical carcinoma from Indian population.

Authors:  M Shabbir Alam; Asgar Ali; Syed Jafar Mehdi; Nisreen Sherif Alyasiri; Zakia Kazim; Swaraj Batra; A K Mandal; M Moshahid Alam Rizvi
Journal:  Tumour Biol       Date:  2011-09-20

2.  Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.

Authors:  Véronique Fontaine; Corinne Mascaux; Christine Weyn; Aurore Bernis; Nathalie Celio; Philippe Lefèvre; Leonard Kaufman; Christian Garbar
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

Review 4.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.

Authors:  E L Franco; E Duarte-Franco; A Ferenczy
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

6.  Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.

Authors:  Chandrika J Piyathilake; Suguna Badiga; Michelle M Chambers; Ilene K Brill; Roland Matthews; Edward E Partridge
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

7.  IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.

Authors:  Hugo Sousa; Alexandra M Santos; Raquel Catarino; Daniela Pinto; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 8.  How will HPV vaccines affect cervical cancer?

Authors:  Richard Roden; T-C Wu
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

9.  Impact of improved classification on the association of human papillomavirus with cervical precancer.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

10.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.